These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 15198545)
21. Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release. Vaishya RD; Mandal A; Patel S; Mitra AK Int J Pharm; 2015 Dec; 496(2):676-88. PubMed ID: 26561725 [TBL] [Abstract][Full Text] [Related]
22. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres. Wang J; Wang BM; Schwendeman SP Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856 [TBL] [Abstract][Full Text] [Related]
23. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
24. Polyelectrolyte complex of chondroitin sulfate and peptide with lower pI value in poly(lactide-co-glycolide) microsphere for stability and controlled release. Park W; Na K Colloids Surf B Biointerfaces; 2009 Sep; 72(2):193-200. PubMed ID: 19414243 [TBL] [Abstract][Full Text] [Related]
25. Effect of water on exenatide acylation in poly(lactide-co-glycolide) microspheres. Liang R; Li X; Shi Y; Wang A; Sun K; Liu W; Li Y Int J Pharm; 2013 Sep; 454(1):344-53. PubMed ID: 23872225 [TBL] [Abstract][Full Text] [Related]
26. Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres. Duggirala SS; Mehta RC; DeLuca PP Pharm Dev Technol; 1996 Apr; 1(1):11-9. PubMed ID: 9552326 [TBL] [Abstract][Full Text] [Related]
27. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Jackson JK; Hung T; Letchford K; Burt HM Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895 [TBL] [Abstract][Full Text] [Related]
28. A novel in vitro release technique for peptide containing biodegradable microspheres. Kostanski JW; DeLuca PP AAPS PharmSciTech; 2000 Mar; 1(1):E4. PubMed ID: 14727853 [TBL] [Abstract][Full Text] [Related]
29. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release. Liang D; Frank S; Schwendeman SP Drug Deliv Transl Res; 2024 Mar; 14(3):696-704. PubMed ID: 38038895 [TBL] [Abstract][Full Text] [Related]
30. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol. Xinteng Z; Weisan P; Ruhua Z; Feng Z Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951 [TBL] [Abstract][Full Text] [Related]
31. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers. Elkheshen SA; Radwan MA J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083 [TBL] [Abstract][Full Text] [Related]
32. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. Duvvuri S; Janoria KG; Mitra AK J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919 [TBL] [Abstract][Full Text] [Related]
33. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Díez S; Tros de Ilarduya C Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172 [TBL] [Abstract][Full Text] [Related]
34. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers. Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156 [TBL] [Abstract][Full Text] [Related]
35. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. Bae SE; Son JS; Park K; Han DK J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089 [TBL] [Abstract][Full Text] [Related]
36. Effect of gamma-irradiation on peptide-containing hydrophilic poly (d,l-lactide-co-glycolide) microspheres. Shameem M; Lee H; Burton K; Thanoo BC; Deluca PP PDA J Pharm Sci Technol; 1999; 53(6):309-13. PubMed ID: 10754729 [TBL] [Abstract][Full Text] [Related]
37. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers. Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474 [TBL] [Abstract][Full Text] [Related]
38. Ketotifen-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers: characterization and in vivo evaluation. Guerrero S; Muñíz E; Teijón C; Olmo R; Teijón JM; Blanco MD J Pharm Sci; 2008 Aug; 97(8):3153-69. PubMed ID: 18023014 [TBL] [Abstract][Full Text] [Related]